AzTrials
AzTrials

Strabismus, DivergentNCT07373197

Lateral Rectus Muscle Strangulation in Cases of Exotropia

A study testing Muscle strangulation in people with Strabismus, Divergent, run by Sohag University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of our study to evaluate effect of lateral rectus muscle strangulation as a novel effective weakening technique in cases of exotropia. It is a case-series intervensional study with a total 12 participant who are diagnosed as exophoria or intermittent exotropia who are older than 4 years old. Read more about this study

Who is it for?
Ages 15 to 50 years
Conditions the study is for
Strabismus, Divergent
What is being tested?
Muscle strangulation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteEgypt
Study dates
1 Jan 2024to 2 Feb 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 50 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • intermittent exotropia

Who cannot join

  • previous squint surgery

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Sohag University

    Sohag

Other trials in Egypt

About this study

Official title: Lateral Rectus Muscle Strangulation: A New Weakening Technique in Cases of Exotropia

The goal of our study to evaluate effect of lateral rectus muscle strangulation as a novel effective weakening technique in cases of exotropia.

It is a case-series intervensional study with a total 12 participant who are diagnosed as exophoria or intermittent exotropia who are older than 4 years old.

All patients will be assessed regarding their angle of deviation and then undergo lateral rectus muscle strangulation under general anesthesia and then will be followed- up at 1st day, 1st week, 1st month and 6th months.

Read the detailed description

Under general anesthesia and after sterilization and draping of the eyes, an eye speculum is inserted. The muscle is exposed and hooked through either a fornix-based or limbal-based incision. Careful dissection is carried out to delineate the muscle edge, a previously measured blook of the lateral rectus muscle is sutured (strangulated) with proline 10/0 as in (fig-1). Patients will be followed-up next day after surgery then after 1 month and after 6 months.

Being tested
Muscle strangulation
Keywords
Exotropia, Lateral rectus muscle
Medical subject headings
Exotropia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Muscle strangulationProcedure or surgery

    lateral rectus muscle strangulation as a weakening technique in cases of exotropia.

Study groups in NCT07373197
Study groupRoleWhat they receive
lateral rectus muscle strangulationExperimentallateral rectus muscle strangulation as a weakening technique in cases of exotropia.
Receives: Procedure: Muscle strangulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correction of strabismus

    the correction was done by lateral rectus muscle strangulation

    Measured: 12 months

Secondary outcomes (1)
  1. orthophoria

    to make both eyes aligned together, and to maintain orthophoria

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jan 2026
  2. Study start1 Jan 2024
  3. Primary completion1 Jul 2024
  4. Study completion2 Feb 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07373197
Sponsor's protocol ID
Soh-Med-24-09-12PD
Status last verified
Sep 2025
First submitted
25 Sep 2025
Last updated
28 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: we havenot decided until now to share IPD with other researchers

Publications

  • Rageh MA, Awadein A, Arfeen SA. Extraocular muscle fenestration: a novel weakening procedure. Can J Ophthalmol. 2020 Oct;55(5):455-457. doi: 10.1016/j.jcjo.2020.05.018. Epub 2020 Aug 26. No abstract available.

    PubMed 32860744
  • Taher SG, Rageh MA, Hashem O. Extra Ocular Muscle Fenestration as a Weakening Maneuver for Surgical Management of Strabismus: A Randomized Pilot Clinical Trial. Clin Ophthalmol. 2022 Jan 8;16:63-70. doi: 10.2147/OPTH.S347092. eCollection 2022.

    PubMed 35035214
  • Koc F, Ozal H, Yasar H, Firat E. Resolution in partially accomodative esotropia during occlusion treatment for amblyopia. Eye (Lond). 2006 Mar;20(3):325-8. doi: 10.1038/sj.eye.6701874.

    PubMed 15933753

Questions about this trial

What is this clinical trial studying?

A study testing Muscle strangulation in people with Strabismus, Divergent, run by Sohag University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correction of strabismus (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07373197, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in